Back
Akero Therapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
55
AKRO
Akero Therapeutics
Last Price:
16.73
Seasonality Move:
-0.92%
Buy
78
MDGL
Madrigal Pharmaceuticals
Last Price:
203.54
Seasonality Move:
35.55%
Buy
55
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $16.66. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $197.36. The Score for MDGL is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $16.66
The current trend is relatively stagnant and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $197.36
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing slight buying pressure.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.3 | Sell |
| Relative Strength Index (14 RSI): | 46.26 | Sell |
| Chaikin Money Flow: | -560846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.77 - 16.11) | Buy |
| Bollinger Bands (100): | (19.33 - 50.89) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 14.54 | Buy |
| Relative Strength Index (14 RSI): | 72.87 | Buy |
| Chaikin Money Flow: | 130035 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (131.06 - 182.92) | Buy |
| Bollinger Bands (100): | (142.07 - 198.19) | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.24 | Buy |
| 20-day SMA: | 15.13 | Buy |
| 50-day SMA: | 23.61 | Sell |
| 200-day SMA: | 39.89 | Sell |
| 8-day EMA: | 16.09 | Buy |
| 20-day EMA: | 16.19 | Buy |
| 50-day EMA: | 22.53 | Sell |
| 200-day EMA: | 34.98 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 190.81 | Buy |
| 20-day SMA: | 164.92 | Buy |
| 50-day SMA: | 149.72 | Buy |
| 200-day SMA: | 217.67 | Sell |
| 8-day EMA: | 187.82 | Buy |
| 20-day EMA: | 171.09 | Buy |
| 50-day EMA: | 162.53 | Buy |
| 200-day EMA: | 184.67 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.14 per share, and an increase next year of $1.38 per share.
Akero Therapeutics Technical Analysis
| Nov 15 | Nov 16 | Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 16 | 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Nov 15 | Nov 16 | Nov 17 | Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 16 | 17 | 20 | 21 | 22 | 24 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||